Pharmacist-guided, Patient-driven Management of High Blood Pressure in CKD: A Novel Approach

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Phase 3
SUMMARY

The proposed research will evaluate if patients managing their blood pressure medications under the guidance of a clinical pharmacist works better to lower blood pressure than patients monitoring their blood pressure at home and the standard care. 60 Veterans with chronic kidney disease (CKD) will be included in the study. The study will further evaluate factors that may influence the Veteran to accept the self-management approach and what factors in the VHA healthcare system affect the implementation of the self-management approach.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age \>= 18 years,

• CKD stage 3 or 4 (estimated GFR: 15-59 mL/min/1.73m2) or

• Stage 2 CKD (estimated GFR 60-89 mL/min/1.73m2) with urinary albumin/creatinine ratio (ACR 300 mg/g if no DM and 30 mg/g if with DM), and

• Uncontrolled hypertension defined as the avg of 2 readings \> 140 systolic.

Locations
United States
Iowa
Iowa City VA Health Care System, Iowa City, IA
RECRUITING
Iowa City
Contact Information
Primary
Diana Jalal, MD
diana.jalal@va.gov
(319) 338-0581
Backup
Katharine M Geasland, RN
KATHARINE-GEASLAND@UIOWA.EDU
(319) 353-6318
Time Frame
Start Date: 2022-12-15
Estimated Completion Date: 2026-11-20
Participants
Target number of participants: 160
Treatments
Experimental: Self-management
Patients monitor their home BP and self manage their BP medications based on a predesigned titration protocol and under the guidance of the clinical pharmacist.
Active_comparator: Self-monitoring
Patients monitor their home BP and contact their provider if the BP is above the goal.
Related Therapeutic Areas
Sponsors
Leads: VA Office of Research and Development

This content was sourced from clinicaltrials.gov